Ariadne Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-922
Closed -$338K 250
2025
Q4
$338K Buy
922
+74
+9% +$23.5K 0.14% 158
2025
Q3
$285K Sell
848
-188
-18% -$54.5K 0.13% 178
2025
Q2
$300K Buy
1,036
+76
+8% +$21.5K 0.14% 156
2025
Q1
$255K Buy
960
+44
+5% +$13K 0.13% 163
2024
Q4
$270K Sell
916
-74
-7% -$22K 0.12% 167
2024
Q3
$319K Buy
+990
New +$324K 0.17% 121

Other funds holding AMGN

Ariadne Wealth Management's AMGN Position: Q1 2026 in Review

Ariadne Wealth Management sold out of Amgen (AMGN) in Q1 2026, closing a stake of 922 shares — an estimated $338K sold.

Ariadne Wealth Management first reported a position in AMGN in Q3 2024 and held it in 6 quarters. The position peaked at $338K in Q4 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Ariadne Wealth Management reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Ariadne Wealth Management sold 922 Amgen shares in Q1 2026, an estimated $338K.
  • Ariadne Wealth Management first reported a position in Amgen in Q3 2024 and held it in 6 quarters.
  • Ariadne Wealth Management's Amgen position peaked at $338K in Q4 2025.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Ariadne Wealth Management's 13F filing for Q1 2026, filed 18 May 2026.